Revisiting Radioresistance: A Systematic Review of Outcomes of Stereotactic Radiosurgery (SRS) in Functional Head and Neck Paragangliomas
Verma O, Mantziaris G, Das L, Sheehan JP, Tripathi M | Neurosurg Rev. | 2025
Hypofractionated Radiosurgery (25 Gy/5 fractions) for Optic Nerve Sheath Meningiomas: Results from an Exploratory Phase 2 Prospective Trial
Fariselli L, Marzoli SB, Morlino S, Pinzi V, Pedone C, De Martin E, Romeo A, Tramacere I, Marchetti M | Int J Radiat Oncol Biol Phys. | 2025
Efficacy and Safety of Donut-Shaped Circumferential Spine CyberKnife Stereotactic Body Radiotherapy for Metastatic Spine Disease
Park DJ, Lee I, Annagiri S, Chou KN, Zamarud A, Akhavan-Sigari A, Hori YS, Persad AR, Abu-Reesh D, Lam FC, Tayag A, Ustrzynski L, Emrich SC, Gu X, Pollom EL, Chang SD | Neurosurgery. | 2025
Computed Tomography Guided Online Adaptive Stereotactic Body Radiation Therapy for Lymph Node Oligometastases: Impact on Dose to Target and Organs at Risk
van Werkhoven LA, Milder MTW, Schillemans W, Hoogeman MS, Nout RA, Nuyttens JJ | Int J Radiat Oncol Biol Phys. | 2025
Pattern of Recurrence After Fractionated Stereotactic Reirradiation in Adult Glioblastoma
Margulies A, Sahki N, Rech F, Vogin G, Blonski M, Peiffert D, Taillandier L, Lesanne G, Demogeot N | Radiat Oncol. | 2025
Low-Burden Oligometastatic Disease of the Lung Treated with Robotic Stereotactic Ablative Radiotherapy: A Retrospective Study
Zygogianni A, Koukourakis IM, Liakouli Z, Desse D, Georgakopoulos I, Armpilia C, Lymperopoulou G, Kouloulias V | Biomedicines. | 2025
Risk-adapted Stereotactic Body Radiation Therapy for the Treatment of Large (>3 cm) Primary Lung Cancer with or without Histologic Confirmation: A Propensity Score Matched and Weighted Analysis
Zeng HY, Li YJ, Ji CZ, Wang HH, Yu XR, He Y, Bai H, Zheng BY, Yan YY, Xu JW, Zaorsky NG, Shi JM, Dong Y, Yu XY, Wang JS, Song YC, Yuan ZY, Chen Y, Meng MB. | Radiother Oncol. | 2025
Local Control and Recurrence Patterns after Stereotactic Irradiation Delivered in more than 4 Fractions for Hepatocellular Carcinomas and liver metastases: a retrospective study
Renan A, Bruand M, Jolnerovski M, Diallo A, Demogeot N | Radiat Oncol. | 2025
Fractionated Robotic Radiosurgery for Unfavorable Nonfunctioning Pituitary Macroadenoma: 5-year Outcomes from a Single Institution Protocol
Bhatnagar A, Marin MP, Lischalk JW, Koh MJ, Agazzi S, Suy S, Harris BT, Sharma ST, Aulisi E, Anaizi A, Khattab MH, Jean WC, Collins SP, Collins BT | Front Oncol. | 2025
A Simple Plan Strategy to Optimize the Biological Effective Dose Delivered in Robotic Radiosurgery of Vestibular Schwannomas
Moutsatsos A, Pantelis E | Phys Med Biol. | 2025
Dosimetric Comparison of CyberKnife and Conventional Linac Prostate Stereotactic Body Radiation Therapy Plans: Analysis of the PACE-B Study
Ratnakumaran R, Sasitharan A, Khan A, Mayet H, Mohajer J, Hinder V, Brand DH, Fullarton R, Loblaw A, Hall E, van As N, Tree AC; PACE trial investigators | Int J Radiat Oncol Biol Phys. | 2025
Multicenter Approach to Predict Plan Quality of Robotic Intracranial SRS/SRT
Landoni V, Broggi S, Serra M, Doro R, Stefania Martinotti A, Redaelli I, Cristina Frassanito M, Siragusa C, De Martin E, Soriani A, Tudda A, Castriconi R, Del Vecchio A, Masi L, Fiorino C | Phys Med. | 2025
Results of a Single Arm Phase II Clinical Trial: Online-Adaptive Stereotactic Body Radiotherapy of Abdominal-Pelvic Oligometastases
van Werkhoven LA, Milder MTW, Hoogeman MS, van Werkhoven E, Nout RA, Nuyttens JJ | Int J Radiat Oncol Biol Phys. | 2025
Fractionated Stereotactic Radiotherapy of Brainstem Metastases – Clinical Outcome and Prognostic Factors
Krämer A, Hahnemann L, Schunn F, Grott CA, Thomas M, Christopoulos P, Lischalk JW, Hörner-Rieber J, Hoegen-Saßmannshausen P, Eichkorn T, Deng MY, Meixner E, Lang K, Paul A, Weykamp F, Debus J, König L | Clin Transl Radiat Oncol. | 2025
Long-Term Outcomes After CyberKnife Radiosurgery for Nonfunctioning Pituitary Adenomas
Wei N, Gunawan K, Tsai CL, Yang SH, Hsu FM, Lai DM, Xiao F | Neurosurgery. | 2025
Lung-heart Toxicity in a Randomized Clinical Trial of Hypofractionated Image Guided Radiation Therapy for Breast Cancer
Van Parijs H, Cecilia-Joseph E, Gorobets O, Storme G, Adriaenssens N, Heyndrickx B, Verschraegen C, Nguyen NP, De Ridder M, Vinh-Hung V | Front Oncol. | 2025
Toxicity of Dose-escalated, Hypofractionated Helical TomoTherapy for Inoperable Thoracic Esophageal Squamous Cell Carcinoma
Zhang SM, Sun J, Pan XO, Zhu WC, Zhou YK | World J Clin Oncol | 2025
Long-term Cardiac Outcomes in Breast Cancer Patients Treated with Helical TomoTherapy: Evaluating the Applicability of 3D-based Dose Constraints for Intensity Modulated Radiation Therapy
Loap P, Uakkas A, Bouziane J, Fourquet A, Kirova Y | Int J Cancer | 2025
Automated Deep Inspiration Breath-Hold (DIBH) in Breast Radiotherapy: A Comprehensive Assessment of the VitalHold System on the Radixact Platform
Retif P, Djibo Sidikou A, Gribelbauer J, Al Salah A, Pfletschinger E, Michel X | Phys Med | 2025
A Dosimetric Comparison of Helical TomoTherapy Treatment Delivery with Real-time Adaption and No Motion Correction
Hindmarsh J, Crowe S, Johnson J, Sengupta C, Walsh J, Dieterich S, Booth J, Keall P | Phys Imaging Radiat Oncol | 2025
